Results 1 to 5 of 31

CMS Issues Final Rule Requiring the Disclosure of Drug List Prices in Direct-to-Consumer Television Ads

USA - May 14 2019 The Final Rule Requires Manufacturers to Disclose List Prices of Prescription Drugs and Biological Products in Television Advertisements On May 8…

John D Shakow, Brian Bohnenkamp, Sheldon Bradshaw, Lisa M. Dwyer, Ashley C. Parrish

Congress Acts to Eliminate MDRP Misclassification

USA - April 22 2019 President Trump on Thursday signed into law the most extensive set of amendments to the Medicaid Drug Rebate Program statute since the Affordable Care…

John D Shakow, Brian Bohnenkamp, David J. Farber, Elizabeth F. Lindquist

HHS Proposes Rule Challenging Drug Manufacturer Rebates to PBMs and Payors

USA - February 4 2019 The Proposed Rule Would Make Clear that the Anti-Kickback Statute’s Discount Safe Harbor Does Not Protect Manufacturer Rebates to PBMs or Payors, But…

John D Shakow, Gina Cavalier, Brian Bohnenkamp, David J. Farber, Preeya Noronha Pinto

AdvaMed Updates Code of Ethics on Interactions with U.S. Health Care Professionals

USA - January 9 2019 The Updated Code Includes Several New Topics and Additional Guidelines on Existing Topics The Advanced Medical Technology Association (AdvaMed)…

Terrence B Burek, Gina Cavalier, Brian Bohnenkamp, Nikki Reeves

CMS proposes sweeping changes to Medicare reimbursement for clinical diagnostic laboratory tests

USA - November 2 2015 In the October 1, 2015 Federal Register, the Centers for Medicare & Medicaid Services (CMS) published a proposed rule outlining extensive revisions…

Terrence B Burek, John D Shakow, David J. Farber, Elizabeth F. Lindquist, Preeya Noronha Pinto